Healthcare provider profile · identity verified

Bohdan Martynec, M.D.

Internal Medicine · DOYLESTOWN, PA · NPI 1760484521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1048	246
Levothyroxine Sodium	Levothyroxine Sodium	651	139
Amlodipine Besylate	Amlodipine Besylate	497	120
Rosuvastatin Calcium	Rosuvastatin Calcium	285	63
Eliquis	Apixaban	279	49
Losartan Potassium	Losartan Potassium	279	65
Omeprazole	Omeprazole	271	66
Gabapentin	Gabapentin	265	61
Lisinopril	Lisinopril	263	63
Sertraline Hcl	Sertraline Hcl	254	49
Simvastatin	Simvastatin	246	55
Donepezil Hcl	Donepezil Hcl	234	36
Furosemide	Furosemide	222	41
Pantoprazole Sodium	Pantoprazole Sodium	211	61
Escitalopram Oxalate	Escitalopram Oxalate	192	44
Metoprolol Succinate	Metoprolol Succinate	185	50
Tamsulosin Hcl	Tamsulosin Hcl	175	49
Metformin Hcl	Metformin Hcl	169	46
Lorazepam	Lorazepam	153	53
Ezetimibe	Ezetimibe	152	37
Finasteride	Finasteride	144	33
Duloxetine Hcl	Duloxetine Hcl	141	32
Hydralazine Hcl	Hydralazine Hcl	131	25
Hydrochlorothiazide	Hydrochlorothiazide	130	37
Pravastatin Sodium	Pravastatin Sodium	124	33
Trazodone Hcl	Trazodone Hcl	120	29
Synthroid	Levothyroxine Sodium	117	26
Famotidine	Famotidine	116	26
Glimepiride	Glimepiride	113	21
Zolpidem Tartrate	Zolpidem Tartrate	108	31
Clopidogrel	Clopidogrel Bisulfate	107	20
Metformin Hcl Er	Metformin Hcl	107	31
Jardiance	Empagliflozin	101	17
Mirtazapine	Mirtazapine	94	29
Ipratropium Bromide	Ipratropium Bromide	90	34
Allopurinol	Allopurinol	87	23
Carvedilol	Carvedilol	86	22
Memantine Hcl	Memantine Hcl	84	17
Potassium Chloride	Potassium Chloride	84	17
Alprazolam	Alprazolam	78	27
Montelukast Sodium	Montelukast Sodium	76	23
Tramadol Hcl	Tramadol Hcl	75	32
Metoprolol Tartrate	Metoprolol Tartrate	72	17
Ozempic	Semaglutide	64	11
Prednisone	Prednisone	63	28
Citalopram Hbr	Citalopram Hydrobromide	62	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	12
Spironolactone	Spironolactone	60	19
Atenolol	Atenolol	59	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	58	43
Midodrine Hcl	Midodrine Hcl	54	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Jantoven	Warfarin Sodium	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	49	21
Doxycycline Hyclate	Doxycycline Hyclate	47	27
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	suppressed
Methenamine Hippurate	Methenamine Hippurate	45	suppressed
Aripiprazole	Aripiprazole	44	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	42	suppressed
Celecoxib	Celecoxib	42	suppressed
Valsartan	Valsartan	42	11
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Clonazepam	Clonazepam	40	13
Latanoprost	Latanoprost	40	suppressed
Januvia	Sitagliptin Phosphate	39	suppressed
Bupropion Xl	Bupropion Hcl	36	13
Buspirone Hcl	Buspirone Hcl	36	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Azithromycin	Azithromycin	33	16
Oseltamivir Phosphate	Oseltamivir Phosphate	32	32
Alendronate Sodium	Alendronate Sodium	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Nystop	Nystatin	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Budesonide	Budesonide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Albuterol Sulfate	Albuterol Sulfate	26	suppressed
Mupirocin	Mupirocin	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Baclofen	Baclofen	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Gemtesa	Vibegron	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	23	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Cephalexin	Cephalexin	23	17
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Methylprednisolone	Methylprednisolone	23	20
Ondansetron Odt	Ondansetron	23	16
Irbesartan	Irbesartan	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nystatin	Nystatin	22	14
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Meloxicam	Meloxicam	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Ramipril	Ramipril	21	suppressed
Admelog Solostar	Insulin Lispro	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Glipizide	Glipizide	17	suppressed
Risperidone	Risperidone	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	16	suppressed
Silodosin	Silodosin	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diazepam	Diazepam	14	suppressed
Estradiol	Estradiol	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Restasis	Cyclosporine	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Torsemide	Torsemide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Belsomra	Suvorexant	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error